Share
PrintTest Details
Cancer TypeUse
The test is a NGS multi-gene panel that assesses circulating tumor DNA (CtDNA) from a plasma sample in patients with non-small cell lung cancer. It is intended to identify key driver mutations and variants to enable treatment decisions for patients.
Special Instructions
Specimen must be submitted using the Integrated Oncology Liquid Biopsy Kit and the Integrated Oncology Gene Profiling Assays test request form (ONC-793).
Please direct any questions regarding this test to Integrated Oncology customer service at 800-710-1800.
Methodology
Next Generation Sequencing
Specimen Requirements
Information on collection, storage, and volume
Specimen
Whole blood
Volume
2 tubes of 10 mL each
Minimum Volume
2 tubes of 10 mL each
Container
Only the Integrated Oncology Liquid Biopsy Kit (PS No. 127647) can be used for collection.
Storage Instructions
Room temperature. Do not refrigerate or freeze. Keep out of direct sunlight. Samples must be shipped to LabCorp in an Integrated Oncology Liquid Biopsy Kit.
Causes for Rejection
Samples not collected and submitted in Streck tubes; specimens submitted in expired or incorrect blood tubes; quantity not sufficient for anlysis; received more than five days from collection; frozen specimens
Collection
Collect 10 mL of whole blood into each of 2 Streck BCT tubes supplied in the Integrated Oncology Liquid Biopsy Kit.
